SPOTLIGHT -
September 5th 2025
Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.
September 4th 2025
A new study finds extreme pregnancy nausea often leads to emotional distress and highlights a need for better care.
The USPSTF cites a lack of strong data to support routine screening or supplementation for iron deficiency in asymptomatic pregnant individuals.
September 3rd 2025
A study highlights common, preventable risk factors such as obesity and diabetes that could impact outcomes.
September 2nd 2025
An international review found rising maternal age, increasing complications, and ongoing disparities in maternity care across 3 nations.
Prenatal exposure to PFAS linked to higher adolescent blood pressure in diverse birth cohort
In a recent study, prenatal PFAS exposure was linked to higher adolescent blood pressure, with stronger effects in boys and children born to non-Hispanic Black mothers.
Read More
Contemporary OB/GYN week in review: Preeclampsia screening, BV treatment, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Postmortem ultrasound accurately estimates gestational age
A new study shows extrauterine cerebellar ultrasound is a reliable, low-cost method to assess gestational age after fetal or neonatal death, especially in low-resource settings.
MRI study links eclampsia to cerebral infarcts, edema, and vasospasm
New research reveals that women with eclampsia show significantly higher rates of brain abnormalities, offering insight into unexplained neurologic symptoms during pregnancy.
Daily antibiotic use during pregnancy may reduce risk of preterm birth
Daily trimethoprim–sulfamethoxazole in pregnancy reduced preterm births, especially in women with HIV, but did not significantly affect birth weight.
Eran Bornstein, MD explains the need for first trimester preeclampsia screening
Comprehensive first trimester screening can identify over 90% of early preeclampsia cases, allowing timely intervention with low-dose aspirin to significantly reduce risks for both mother and baby.
Watch
Contemporary OB/GYN week in review: Postpartum psychosis, preeclampsia risk, and more
Racial disparities found in severe maternal morbidity after cesarean delivery
A new study reveals higher rates of severe maternal complications among Black and Hispanic patients with prior cesarean births, highlighting the need for equity-focused care strategies.
Veerle Bergink, MD, PhD, highlights familial links of postpartum psychosis
Learn how postpartum psychosis impacts maternal health, the role of family history, and key steps to identify and prevent this serious but treatable condition.
Ivie Odiase, MD, on universal aspirin implementation for reducing preeclampsia risk
A universal aspirin initiative at a Bronx hospital increased prescribing rates from 30% to 99% and is now being evaluated for its impact on preeclampsia.
Postpartum psychosis risk 10-fold higher with sibling history
New research reveals a strong genetic connection in postpartum psychosis, emphasizing the need for early screening in high-risk women.
Contemporary OB/GYN week in review: Dense breasts, stroke risk, and more
Study finds sharp decline in US maternal mental health
A new study reveals worsening mental and physical health among female parents, highlighting growing disparities across race, income, and family structure.
CDC removes COVID-19 vaccine recommendation for healthy children, pregnant individuals
RFK Jr. stated he "couldn't be more pleased" to announce that COVID-19 vaccination among healthy children and pregnant women has been removed from CDC's immunization schedule.
Preeclampsia prevention improved by 150 mg aspirin vs 75 mg
A new study finds that a daily 150 mg dose of aspirin significantly improves thromboxane B2 inhibition compared to 75 mg in pregnant women at risk for preeclampsia.
Contemporary OB/GYN week in review: ACOG 2025, prenatal diabetes, and more
Study finds biologic use drops during pregnancy in autoimmune patients
A study found that biologic treatment rates decline during pregnancy and only partially rebound postpartum, with trends varying by autoimmune condition.
Antenatal corticosteroids reduce neonatal mortality in preterm births
A study found the greatest reduction in neonatal mortality occurs when antenatal corticosteroids are given 24 hours to 14 days before preterm delivery.
Amy Valent DO, MCR, highlights new tech for prenatal diabetes management
Amy Valent, DO, MCR, discusses how continuous glucose monitors and smart insulin delivery tools are reshaping individualized care for pregnant patients with diabetes.
Use of hair, cosmetic products linked to increased phthalate exposure in pregnancy
Research presented at the 2025 ACOG ACSM highlighted the potential risks tied to personal care product use among African American pregnant patients.
Johanna Finkle, MD, on weight loss management in reproductive-aged patients
In this interview at the 2025 ACOG ACSM, Johanna Finkle, MD, urged clinicians to tailor weight loss care based on BMI, contraception use, and medication risks using patient-centered counseling.
Intimate partner violence linked to shorter interpregnancy interval
A study presented at the 2025 ACOG Annual Clinical & Scientific Meeting found women who experience intimate partner violence are more likely to have short interpregnancy intervals and mental health disorders.
Air pollution linked to risk spontaneous preterm birth risk
A study presented at the 2025 ACOG Annual Clinical & Scientific Meeting found that fine particulate matter exposure during pregnancy is associated with increased odds of spontaneous preterm birth.
Laxmi Gannu, MS, notes PPD screening gaps and adverse outcomes
Despite widespread awareness of guidelines, many health care providers fall short in consistently screening and referring postpartum women for depression, putting maternal mental health at risk.
Farah Amro, MD, discusses leaving the placenta in situ for patients with placenta accreta spectrum
Farah Amro, MD, shares her research at the 2025 ACOG ACSM on leaving the placenta in situ in select patients with placenta accreta spectrum.
Laurence Shields, MD, compares postpartum hemorrhage control devices
Laurence Shields, MD, shares details from his latest study on hemorrhage control devices for postpartum hemorrhage at the 2025 ACOG ACSM.
Early data show disparities in RSV vaccine uptake among pregnant patients
A new study presented at 2025 ACOG Annual Clinical and Scientific Meeting found disparities between RSV uptake in pregnant patients.
Joy Baker, MD, FACOG, highlights how to recognize postpartum depression
Postpartum depression often goes undiagnosed because of a lack of screening and stigma—learn how early detection, open conversations, and new treatment options can improve outcomes for mothers.
A discussion on ACOG’s new clinical consensus on tailored prenatal care
In this Q&A, experts explain how ACOG’s tailored prenatal care model supports flexibility, equity, and shared decision-making in pregnancy.
Physiotherapy during labor reduces c-section and birth injury
A new study presented at the 2025 ACOG Annual Clinical & Scientific Meeting reveals that physiotherapy support during labor lowers the chances of cesarean delivery, severe perineal tears, and labor pain.